These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20462385)

  • 1. Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications.
    Candore G; Bulati M; Caruso C; Castiglia L; Colonna-Romano G; Di Bona D; Duro G; Lio D; Matranga D; Pellicanò M; Rizzo C; Scapagnini G; Vasto S
    Rejuvenation Res; 2010; 13(2-3):301-13. PubMed ID: 20462385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease.
    Mas E; Dupuy AM; Artero S; Portet F; Cristol JP; Ritchie K; Touchon J
    Dement Geriatr Cogn Disord; 2006; 21(3):198-204. PubMed ID: 16407653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE and cholesterol homeostasis in Alzheimer's disease.
    Leduc V; Jasmin-Bélanger S; Poirier J
    Trends Mol Med; 2010 Oct; 16(10):469-77. PubMed ID: 20817608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.
    Martins IJ; Hone E; Foster JK; Sünram-Lea SI; Gnjec A; Fuller SJ; Nolan D; Gandy SE; Martins RN
    Mol Psychiatry; 2006 Aug; 11(8):721-36. PubMed ID: 16786033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease.
    Poirier J
    Neurobiol Aging; 2005 Mar; 26(3):355-61. PubMed ID: 15639314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.
    Lombardi VR; García M; Cacabelos R
    J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immune system and Alzheimer's disease].
    van Exel E; Eikelenboom P; Comijs HC; Kurniawan C; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Tijdschr Psychiatr; 2011; 53(9):637-43. PubMed ID: 21898320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of lipids in Alzheimer's disease.
    Lim WL; Martins IJ; Martins RN
    J Genet Genomics; 2014 May; 41(5):261-74. PubMed ID: 24894353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E in the brain and its role in Alzheimer's disease.
    Poirier J
    J Psychiatry Neurosci; 1996 Mar; 21(2):128-34. PubMed ID: 8820179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
    Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ
    Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders.
    Itzhaki RF; Wozniak MA
    Prog Lipid Res; 2006 Jan; 45(1):73-90. PubMed ID: 16406033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.
    Mann KM; Thorngate FE; Katoh-Fukui Y; Hamanaka H; Williams DL; Fujita S; Lamb BT
    Hum Mol Genet; 2004 Sep; 13(17):1959-68. PubMed ID: 15229191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
    Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
    Austen B; Christodoulou G; Terry JE
    J Nutr Health Aging; 2002; 6(6):377-82. PubMed ID: 12459888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology and pharmacotherapy of Alzheimer's disease.
    Felician O; Sandson TA
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of apolipoprotein E in the pathogenesis of Alzheimer disease].
    Okuizumi K
    Nihon Rinsho; 1999 Dec; 57(12):2673-7. PubMed ID: 10638195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.